Acanthamoeba keratitis--resistance to medical therapy

Eye
L FickerP Wright

Abstract

Successful medical therapy of Acanthamoeba keratitis has been reported with combination therapy; topical Brolene and neomycin. Resistance has not so far been identified as a problem, but was the basis for recurrent disease observed in a patient with bilateral infection. Eradication of amoebae was finally achieved following prolonged topical therapy and two corneal grafts in each eye. Topical anti-amoebic therapy with paromomycin, benzethonium chloride, clotrimazole and R11/29 (a phenanthridinium compound), was continued for three months post-operatively. No further recurrences occurred during 14 months' follow-up. Drug sensitivities were performed for three isolates of Acanthamoeba sp (group II) which demonstrated the development of resistance to Brolene and arsenic. In addition, the resistant isolates were temperature-sensitive mutants which would not grow at temperatures above 30 degrees C. This could explain 'culture-negative' results in some cases of clinical recurrence when incubation of laboratory samples had only been performed at 37 degrees C.

References

Oct 1, 1985·The British Journal of Ophthalmology·P WrightB R Jones

❮ Previous
Next ❯

Citations

Dec 18, 2013·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·N SzentmáryB Seitz
May 9, 2009·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Weiyun ShiLixin Xie
Jul 18, 2008·Parasitology Research·Narumon BoonmanAraya Dharmkrong-at Chusattayanond
Dec 4, 2008·Parasitology Research·Monika DerdaBarbara Thiem
Jul 13, 2011·Parasitology Research·Zubeyde Akın PolatJulia Walochnik
Apr 10, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Frederick L Schuster, Govinda S Visvesvara
Apr 14, 1999·Ophthalmology·P KosrirukvongsG S Visvesvara
Jun 5, 2003·Microbial Pathogenesis·Naveed Ahmed Khan
Jan 1, 1991·Eye·L FickerD Seal
Mar 8, 2007·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Aysen TopalkaraAli Cetin
Mar 29, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Zubeyde Akin PolatAli Cetin
May 20, 2009·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ismihan GozeZubeyde Akin Polat
Jun 25, 2009·The Journal of Antimicrobial Chemotherapy·Julia WalochnikHerbert Auer
Nov 28, 2007·Antimicrobial Agents and Chemotherapy·Ursula FürnkranzJulia Walochnik
Feb 1, 1995·Antimicrobial Agents and Chemotherapy·D PerrineM Robba
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·Julia WalochnikHorst Aspöck
Apr 15, 2003·Clinical Microbiology Reviews·Francine Marciano-Cabral, Guy Cabral
Feb 22, 2005·The British Journal of Ophthalmology·P P SyamJ van der Hoek
Apr 30, 1994·BMJ : British Medical Journal·D V Seal
Apr 1, 1993·Journal of Clinical Pathology·J HayC M Kirkness
Sep 7, 2012·AMB Express·Ruqaiyyah Siddiqui, Naveed Ahmed Khan
Mar 25, 1995·Lancet·M J Elder, J K Dart
Apr 25, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maizatul Akma IbrahimNakisah Mat Amin
Jul 8, 2000·Tropical Medicine & International Health : TM & IH·S JongwutiwesT Endo
Feb 1, 1992·Ophthalmology·D F LarkinJ K Dart
Jan 1, 1993·Ophthalmology·L A FickerP Wright
Jan 20, 2016·Parasitology Research·Monika DerdaAgnieszka Wojtkowiak-Giera
Jan 29, 2008·American Journal of Ophthalmology·Kirk R WilhelmusMitchell P Weikert
Apr 23, 2013·Clinical & Experimental Ophthalmology·Zubeyde A PolatMustafa K Arici
Mar 1, 1996·The Journal of Infection·F B KinnearD V Seal
Aug 18, 2004·International Journal for Parasitology·Frederick L Schuster, Govinda S Visvesvara

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.